Rainier Acquisition (RNAQU) traded flat 0 % during a 24 hours period ending at 01:26 PM Central Europe on Tuesday 27th. One Rainier Acquisition stock can currently be bought for about USD 10.03 on popular exchanges. Current supply of Rainier Acquisition stocks is 9.6 mn. Rainier Acquisition has a current market capitalization of USD 96 mn and approximately USD 6 k worth of Rainier Acquisition was traded on exchanges in the last 24 hours. Since last month end, Rainier Acquisition has traded -1.47 % down. Simple moving average of last 200 days is at USD 10.15. The highest price of past 52 weeks was recorded at USD 10.38 on 09/03/2026. 52 weeks low was at USD 10.01 on 10/06/2026.
Here is how related stocks have performed in the past 24 hours:
Provident (PROV) traded down -0.22 % and now trades at USD 18.16. Provident has a market capitalisation of USD 113.2 mn. Provident has a current price to earnings ratio of 17.67.
Plum Acquisition Iv (PLMK) traded down -0.02 % and now trades at USD 10.62. Current market capitalisation for Plum Acquisition Iv is USD 113.7 mn. Current price/earnings ratio for Plum Acquisition Iv is 51.31.
Tcgx Acquisition (TCGX) traded up 0.4 % and now trades at USD 10.14. Tcgx Acquisition has a market capitalisation of USD 114.2 mn. TCGX ACQUISITION CORP participated in the recent equity offering by Aclaris Therapeutics, contributing to a transaction that combines common shares with pre‑funded warrants. The deal is structured to raise a substantial amount of capital, reflecting the market’s willingness to support Aclaris’s growth strategy. The inclusion of pre‑funded warrants indicates a forward‑looking approach, allowing investors to acquire shares at a price closely aligned with the current market level. While the offering will increase the total share count, the terms suggest a modest impact on existing ownership proportions. The transaction is expected to close in late October, contingent upon standard closing conditions. The involvement of TCGX ACQUISITION CORP underscores its role in facilitating capital formation for emerging biopharmaceutical companies.
Team (TISI) traded down -1.61 % and now trades at USD 23.81. Team has a market capitalisation of USD 110.9 mn.
Dmc Global (BOOM) traded down -2.19 % and now trades at USD 5.37. Dmc Global has a market capitalisation of USD 112.8 mn.